Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 186 | 256 | 184 | 214 | 235 |
| Gross Profit | 186 | 256 | 184 | 214 | 235 |
| Operating Expenses | 5,470 | 6,088 | 5,358 | 6,929 | 6,395 |
| Operating Income | -5,284 | -5,832 | -5,174 | -6,715 | -6,160 |
| Interest Expense | 2 | 2 | 1 | 1 | 2 |
| Other Income | 39 | -1,168 | 2,551 | 13 | 618 |
| Pre-tax Income | -5,247 | -7,002 | -2,624 | -6,703 | -5,544 |
| Net Income Continuous | -5,247 | -7,002 | -2,624 | -6,703 | -5,544 |
| Net Income | $-5,247 | $-7,002 | $-2,624 | $-6,703 | $-5,544 |
| EPS Basic Total Ops | -3.25 | -4.75 | -2.00 | -5.00 | -4.25 |
| EPS Basic Continuous Ops | -3.26 | -4.68 | -1.97 | -5.11 | -4.23 |
| EPS Diluted Total Ops | -3.25 | -4.75 | -2.00 | -5.00 | -4.25 |
| EPS Diluted Continuous Ops | -3.26 | -4.68 | -1.97 | -5.11 | -4.23 |
| EBITDA(a) | $-5,034 | $-5,584 | $-4,952 | $-6,534 | $-5,986 |